Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Leykin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Omics : a Journal of Integrative Biology|October 8, 2005
HumanUpstream and MouseUpstream: databases of promoter sequences in the human and mouse genomesIgor Leykin, Ming-Chih J Kao, Wing Hung Wong
Diabetes|January 30, 2004
Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunityBoris Nikolic, Yasuo Takeuchi, Igor Leykin, et al.
Transplantation|January 12, 2010
Distinct requirements for achievement of allotolerance versus reversal of autoimmunity via nonmyeloablative mixed chimerism induction in NOD miceBoris Nikolic, Takashi Onoe, Yasuo Takeuchi, et al.
Nature|April 23, 2002
Extensive and divergent circadian gene expression in liver and heartKai-Florian Storch, Ovidiu Lipan, Igor Leykin, et al.
Chemistry & Biology|May 29, 2003
Chemical genetic modifier screens: small molecule trichostatin suppressors as probes of intracellular histone and tubulin acetylationKathryn M Koeller, Stephen J Haggarty, Brian D Perkins, et al.
BMC Genetics|February 17, 2005
Comparative linkage analysis and visualization of high-density oligonucleotide SNP array dataIgor Leykin, Ke Hao, Junsheng Cheng, et al.
Aging Cell|November 16, 2007
Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out miceMasa Katic, Adam R Kennedy, Igor Leykin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2011
A point mutation in the amino terminus of TLR7 abolishes signaling without affecting ligand bindingCarlo Iavarone, Katrin Ramsauer, Andriy V Kubarenko, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Omics : a Journal of Integrative Biology|October 8, 2005
HumanUpstream and MouseUpstream: databases of promoter sequences in the human and mouse genomesIgor Leykin, Ming-Chih J Kao, Wing Hung Wong
Diabetes|January 30, 2004
Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunityBoris Nikolic, Yasuo Takeuchi, Igor Leykin, et al.
Transplantation|January 12, 2010
Distinct requirements for achievement of allotolerance versus reversal of autoimmunity via nonmyeloablative mixed chimerism induction in NOD miceBoris Nikolic, Takashi Onoe, Yasuo Takeuchi, et al.
Nature|April 23, 2002
Extensive and divergent circadian gene expression in liver and heartKai-Florian Storch, Ovidiu Lipan, Igor Leykin, et al.
Chemistry & Biology|May 29, 2003
Chemical genetic modifier screens: small molecule trichostatin suppressors as probes of intracellular histone and tubulin acetylationKathryn M Koeller, Stephen J Haggarty, Brian D Perkins, et al.
BMC Genetics|February 17, 2005
Comparative linkage analysis and visualization of high-density oligonucleotide SNP array dataIgor Leykin, Ke Hao, Junsheng Cheng, et al.
Aging Cell|November 16, 2007
Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out miceMasa Katic, Adam R Kennedy, Igor Leykin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2011
A point mutation in the amino terminus of TLR7 abolishes signaling without affecting ligand bindingCarlo Iavarone, Katrin Ramsauer, Andriy V Kubarenko, et al.
Pageof 1